Eli Lilly and Company: all 2,262 studies
Page 11 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Bioavailability Study of LY2452473 and TadalafilCompletedNCT01401543Phase 1Results posted
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
- Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive DeclineCompletedNCT01400425Phase 3Results posted
- A Relative Bioavailability and Food Effect Study of New FormulationsCompletedNCT01398475Phase 1Results posted
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)CompletedNCT01394952Phase 3Results posted
- A Phase 1 Study of LY2835219 In Participants With Advanced CancerCompletedNCT01394016Phase 1Results posted
- A Study of LY2584702 in Participants With Advanced CancerTerminatedNCT01394003Phase 1Results posted
- A Study of LY2228820 in Participants With Advanced CancerCompletedNCT01393990Phase 1Results posted
- A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT01391130Phase 2Results posted
- A Study to Evaluate the Effect of Food on LY2216684CompletedNCT01389765Phase 1Results posted
- A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedNCT01389752Phase 1Results posted
- A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of WarfarinCompletedNCT01388335Phase 1Results posted
- A Study of LY2216684 in Healthy ParticipantsCompletedNCT01380691Phase 1Results posted
- A Study of LY2484595 in Japanese SubjectsCompletedNCT01375075Phase 2Results posted
- A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy SubjectsCompletedNCT01374178Phase 1Results posted
- A Study of LY2216684 in Healthy FemalesCompletedNCT01373931Phase 1Results posted
- A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerCompletedNCT01373164Phase 1/2Results posted
- Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702CompletedNCT01372085Phase 1Results posted
- A Study of LY2216684 in Participants With Major Depression DisorderCompletedNCT01370499Phase 3Results posted
- A Study of LY2495655 in Older Participants Undergoing Elective Total Hip ReplacementCompletedNCT01369511Phase 2Results posted
- Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human ParticipantsCompletedNCT01367262Phase 1Results posted
- A Study of LY2881835 in Healthy People and People With DiabetesCompletedNCT01358981Phase 1Results posted
- A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of DesipramineCompletedNCT01358968Phase 1Results posted
- A Study of LY2409021 Formulations and the Effect of FoodCompletedNCT01354496Phase 1Results posted
- A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in ChinaCompletedNCT01352507Phase 4Results posted
- A Study of IMC-CS4 in Subjects With Advanced Solid TumorsCompletedNCT01346358Phase 1Results posted
- A Study of LY2495655 in Healthy SubjectsCompletedNCT01341470Phase 1Results posted
- A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsCompletedNCT01341457Phase 1Results posted
- A Phase 1 Study of LY2787106 in Cancer and AnemiaCompletedNCT01340976Phase 1Results posted
- A Study of LY2951742 in Healthy VolunteersCompletedNCT01337596Phase 1Results posted
- A First Human Study of a Ferroportin AntibodyCompletedNCT01330953Phase 1Results posted
- A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCompletedNCT01324388Phase 1Results posted
- A Study of LY2828360 in Patients With Osteoarthritic Knee PainCompletedNCT01319929Phase 2Results posted
- A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal TumorsTerminatedNCT01316263Phase 2Results posted
- A Study to Compare Two Forms of LY2608204 in Healthy PeopleCompletedNCT01313286Phase 1Results posted
- A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.CompletedNCT01301092Phase 1Results posted
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
- Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human SubjectsCompletedNCT01299285Phase 1Results posted
- A Study in Prevention of Re-emergence of Depression SymptomsCompletedNCT01299272Phase 3Results posted
- C14 Study in Oncology Patients With Advanced and/or Metastatic Solid TumorsCompletedNCT01296568Phase 1Results posted
- A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid TumorsCompletedNCT01288989Phase 1Results posted
- A Study of LY2090314 in Patients With Advanced or Metastatic CancerCompletedNCT01287520Phase 1Results posted
- A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)CompletedNCT01286818Phase 1Results posted
- A Safety Study in Participants With Advanced Solid TumorsTerminatedNCT01284335Phase 1Results posted
- Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaCompletedNCT01282463Phase 2Results posted
- A Study of the Effect of LY2216684 on LorazepamCompletedNCT01275144Phase 1Results posted
- A Study of LY2216684 and Digoxin in Healthy SubjectsCompletedNCT01266590Phase 1Results posted
- A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsCompletedNCT01263223Phase 1Results posted
- A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCompletedNCT01263197Phase 1Results posted
- A Study of LY2216684 and Warfarin in Healthy SubjectsCompletedNCT01263119Phase 1Results posted
- A Study of LY2216684 and Theophylline in Healthy SubjectsCompletedNCT01263106Phase 1Results posted
- A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelCompletedNCT01263093Phase 1Results posted
- A Phase 1b Trial in Patients With Renal Cell CancerCompletedNCT01258348Phase 1Results posted
- A Study of Ramucirumab (IMC-1121B) in Participants With Breast CancerCompletedNCT01256567Phase 1Results posted
- Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasCompletedNCT01253525Phase 1Results posted
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedNCT01253304Phase 1Results posted
- A Study of Japanese Rheumatoid Arthritis ParticipantsCompletedNCT01253291Phase 1Results posted
- A Study in Rheumatoid ArthritisCompletedNCT01253265Phase 1Results posted
- A Study for Japanese Participants With Rheumatoid Arthritis (RA)CompletedNCT01253226Phase 1Results posted
- A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCompletedNCT01250873Phase 1Results posted
- LY2189265 and Atorvastatin Interaction StudyCompletedNCT01250834Phase 1Results posted
- A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal WomenCompletedNCT01250145Phase 1Results posted
- A Study of LY2608204 in Patients With Type 2 DiabetesCompletedNCT01247363Phase 1Results posted
- A Study of LY3009104(Baricitinib) for Healthy SubjectsCompletedNCT01247350Phase 1Results posted
- A Study of LY2157299 in Participants With Hepatocellular CarcinomaCompletedNCT01246986Phase 2Results posted
- A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerCompletedNCT01246960Phase 2Results posted
- A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
- A Study of LY2584702 in Solid TumorsCompletedNCT01241461Phase 1Results posted
- A Study of LY2409021 in Patients With Type 2 DiabetesCompletedNCT01241448Phase 2Results posted
- A Study of LY2216684 in Participants With Impaired Hepatic FunctionCompletedNCT01241435Phase 1Results posted
- Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium ClearanceCompletedNCT01237899Phase 1Results posted
- A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia SyndromeCompletedNCT01237587Phase 3Results posted
- A Study of LY2439821 in Rheumatoid ArthritisCompletedNCT01236118Phase 1Results posted
- Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy SubjectCompletedNCT01236105Phase 1Results posted
- Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsCompletedNCT01234402Phase 2Results posted
- A Study in Non-Small Cell Lung CancerCompletedNCT01232452Phase 2Results posted
- A Safety Study of LY2886721 Multiple Doses in Healthy SubjectsCompletedNCT01227252Phase 1Results posted
- A Study in Pediatric Participants With Generalized Anxiety DisorderCompletedNCT01226511Phase 3Results posted
- A Study in Advanced CancerCompletedNCT01226485Phase 1Results posted
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
- An Open Label Study for Participants With Rheumatoid ArthritisTerminatedNCT01215942Phase 3Results posted
- A Phase 1 Study in Patients With Solid TumorsCompletedNCT01215916Phase 1Results posted
- Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid TumorsCompletedNCT01214668Phase 1Results posted
- A Study for Patients With Acute LeukemiaTerminatedNCT01214655Phase 1Results posted
- A Dose-Escalation Study for Patients With Advanced CancerCompletedNCT01214642Phase 1Results posted
- A Study for Participants With Advanced CancerCompletedNCT01214629Phase 1Results posted
- A Study in Participants With Acute LeukemiaCompletedNCT01214603Phase 2Results posted
- A Phase 1 Study of LY2874455 in Participants With Advanced CancerCompletedNCT01212107Phase 1Results posted
- A Tasisulam and Midazolam Drug Interaction Study in Cancer PatientsTerminatedNCT01209832Phase 1Results posted
- A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01205438Phase 3Results posted
- A Study of Olaratumab (IMC-3G3) in Prostate CancerCompletedNCT01204710Phase 2Results posted
- A Study in Participants With Rheumatoid ArthritisTerminatedNCT01202773Phase 3Results posted
- A Rheumatoid Arthritis Study in ParticipantsCompletedNCT01202760Phase 3Results posted
- A Study in Participants With End-Stage Renal DiseaseCompletedNCT01200290Phase 2Results posted
- Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid TumorsCompletedNCT01199822Phase 1Results posted
- A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTerminatedNCT01198002Phase 3Results posted
- A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01196091Phase 3Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
- A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentCompletedNCT01187407Phase 3Results posted